Saturday, April 09, 2022

Study finds decrease in racial disparity and increase in survival rates in metastatic breast cancer patients due to Medicaid expansion


 News Release 8-Apr-2022
Findings from study led by Susan G. Komen scholars published in JAMA Oncology
Peer-Reviewed Publication
Susan G. Komen


A new study led by Susan G. Komen® Scholars indicates that patients diagnosed with de novo stage 4 breast cancer – also called metastatic breast cancer– had improved survival rates and decreased mortality rates when those patients had access to care. De novo means the breast cancer was stage 4 at the time of diagnosis and had already spread to distant parts of the body.



No comments:

Post a Comment